Medical Device Tender Document Translation: Where Bids Get Disqualified

One wrong parameter, one dead bid

A provincial centralized procurement round last year. An imaging equipment maker submitted its technical bid with "探测器矩阵" rendered as "detector array." The tender document said "detector matrix." Evaluators compared the English version line by line. Parameter mismatch. Four technical points gone. The bid slid from second to fifth.

This is not an isolated case in medical device tender document translation. A bid is a legal document and a scoring instrument at the same time. A terminology error does not read as awkward. It reads as non-responsive.

What follows is drawn from live projects. The control points matter more than the prose.

Three document types, three risk profiles

Treating "bid translation" as one category is where teams get careless. Tender document translation, bid submission translation, and technical bid translation fail in different ways.

Document type	Core content	Primary risk	Review focus
Tender document translation	Scoring rules, eligibility, contract terms	Misreading leads to wrong response	Map every scoring item
Bid submission translation	Commercial bid, qualifications, track record	Certificate terminology drift	Zero-error on names and numbers
Technical bid translation	Product specs, clinical data, UDI, IFU	Spec errors cost points or void the bid	Lock values, units, model codes

Technical bid translation sits between engineering language and regulatory language. Evaluators must understand the specs, and those specs must match the registration certificate, the IFU, and the test reports.

Technical specs: enforce three-source alignment

Every critical parameter in a medical technical bid usually appears in three places: the registration certificate, the product technical requirements, and the IFU. The wording must agree across all three.

Our internal rule is simple.

1. Lock values and units. No mixed formats like "5–15 mA" alongside "5 to 15 mA." Use the unit system the tender requires.
2. Lock model and specification codes. A model number is an identifier, not a noun. Never translate it, never reflow it.
3. Lock regulatory references. EU MDR 2017/745, IVDR 2017/746, FDA 510(k) — use the official rendering or keep the original, with the full name at first mention.

Miss any one of these and the bid can be judged incomplete.

UDI and IFU: the two quiet failure points

UDI is a code. The DI and PI segments have fixed delimiters and casing. Translators who "tidy up" the format create a defect that is hard to trace later.

IFU is worse. Multilingual IFUs usually have an approved version already. Any indication or contraindication quoted in the bid must match the registered IFU word for word. We have seen "contraindicated" softened into "not recommended." Evaluators read that as a compliance question, and the conversation turns hostile fast.

Qualification and certificate translation

Commercial bids carry ISO 13485 certificates, CE documentation, and free sale certificates. One wrong term triggers a challenge.

• Use the issuing body's official certificate name. Do not invent a translation.
• Verify certificate numbers, validity dates, and scope character by character. A single digit error voids the document.
• Match the scope's product categories to the product being bid. Do not flatten everything into "medical device."

There is no room for paraphrase at this layer. This is proofreading engineering.

A workflow that holds up

Our medical tender translation runs five fixed steps.

1. Term extraction upfront. Build a project glossary before drafting: model codes, parameters, regulatory citations.
2. Bilingual aligned layout. Source and target in parallel paragraphs. Evaluators can verify, and reviewers can trace.
3. Technical review. A reviewer with medical device background checks specs against registration data.
4. Compliance pass. Zero-tolerance fields: UDI, IFU wording, certificate numbers.
5. Version freeze. Lock the final version. Any change goes through a change log.

The process looks heavy. It blocks most disqualification risk. The translator-reviewer-final verifier separation required by ISO 17100:2015 is not paperwork here. It is the mechanism.

When the deadline is days away

Centralized procurement cycles are brutal. The right response is parallelization, not skipping review. Build the glossary early, run technical review and compliance pass concurrently, and reserve final verification for zero-tolerance fields only.

Speed bought by cutting review is usually repaid at disqualification.

If a medical tender is on your desk right now, send over the technical bid and qualification files. We will run a terminology and compliance pre-check before we talk scheduling.